Friedreich Ataxia Scientific News

Friedreich Ataxia and close related scientific news. Topics related to rare diseases.

Tuesday, November 17, 2026

Neuroimmune transcriptional signatures across repeat expansion ataxias in the human brain

›
Chen, Z., Hicks, A.R., Brenton, J. et al. Neuroimmune transcriptional signatures across repeat expansion ataxias in the human brain. Acta Ne...

Targeting Nrf2 Signaling in Friedreich’s Ataxia Cardiomyopathy: Sex-Dependent Therapeutic Responses to Dimethyl Fumarate and Omaveloxolone

›
Figueroa, F.; Salinas, L.; Montgomery-Bowie, C.B.; Sellers, R.; Sims, L.; Cox, G.P.; Golove, S.L.; Thai, P.N.; Chiamvimonvat, N.; Cortopassi...
Monday, November 16, 2026

EE497 Healthcare and Economic Impact of Friedreich's Ataxia in Italy: A Stratified Analysis Based On Patients’ Ambulatory Status

›
Ippazio Cosimo Antonazzo, Paolo Angelo Cortesi, Lorenzo G. Mantovani, Richard Lawson, Leila Khader, Claudia Oliviero, Laura Santoni, Antonio...

Omaveloxolone functions as a molecular crowbar-like degrader of STING to alleviate aging-related inflammation

›
Zhou, J., Ma, X., Jiang, B. et al. Omaveloxolone functions as a molecular crowbar-like degrader of STING to alleviate aging-related inflamma...

Larimar Narrows Q3 Loss; Completes BLA Submission For Nomlabofusp In Friedreich's Ataxia

›
Published: 11/16/2026. Larimar completed its rolling BLA submission to the U.S. Food and Drug Administration (FDA), seeking accelerated appr...
Sunday, November 15, 2026

FXN protomutations are the source of pathogenic expanded GAA alleles in Friedreich ataxia and explain its unequal population distribution

›
Devore MC, Lam C, Xiao E, Devore J, McCain KRC, Wiley G, Park CC, Lynch DR, Bidichandani SI. FXN protomutations are the source of pathogenic...

Integration of Evolutionary Analysis With RFdiffusion for De Novo Design of Aggregation-Resistant Frataxin

›
Kırboğa KK, Küçüksille EU. Integration of Evolutionary Analysis With RFdiffusion for De Novo Design of Aggregation-Resistant Frataxin. Prote...

Nerve ultrasound as a biomarker in Friedreich’s ataxia

›
Giuseppe Di Pietro, Ettore Cioffi, Pietro Falco, Caterina Leone, Giulia Di Stefano, Eleonora Galosi, Gianfranco De Stefano, Valentina Martin...

Sex-based differences in the NRF2 oxidative stress response: Implications for precision therapeutics

›
Giusy Russomanno, Karolina Kwiatkowska, Ian M. Copple, Sex-based differences in the NRF2 oxidative stress response: Implications for precisi...

Nonclinical efficacy and safety evaluation of SGT-212, a novel investigational AAV FXN gene therapy for the treatment of Friedreich’s ataxia

›
Nonclinical efficacy and safety evaluation of SGT-212, a novel investigational AAV FXN gene therapy for the treatment of Friedreich’s ataxia, ...
›
Home
View web version

About Me

My photo
Juan Carlos Baiges
Tortosa, Catalunya, Spain
BSc, MSc (Pharmacy), MSc (Computer science)
View my complete profile
Powered by Blogger.